CLOV
Clover Health Investments, Corp. (Russell 2000)
Healthcare — Healthcare Plans
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Buy
2.3 / 5
3 analysts
$4.34
+$0.07 (+1.52%)
Target:
$4.58
(5.7%)
Sign in to add CLOV to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $2.28B |
| P/E Ratio (TTM) | - |
| Forward P/E | 43.35 |
| EPS (TTM) | $-0.12 |
| Dividend Yield | - |
| Profit Margin | -2.58% |
| Revenue Growth | 62.00% |
| ROE | -16.86% |
| Debt/Equity | - |
| Recommendation | Buy 2.3 |
| Analyst Target | $4.58 |
| Analysts | 3 |
| Indexes | Russell 2000 |
Technical Indicators
| RSI (14) | 42.9 |
| Beta | 2.42 |
| SMA 20 | $4.71 |
| SMA 40 | $4.67 |
| 52-Week High | $5.59 |
| 52-Week Low | $1.58 |
| 50-Day Avg | $4.45 |
| 200-Day Avg | $2.95 |
| Avg Volume | $7.54M |
| Volume | $3.84M |
Performance Analysis
BULLISHCLOV shows predominantly bullish signals based on its fundamentals and technicals.
~
Trading at 69% of its 52-week range.
~
RSI at 42.9 is in neutral territory.
~
Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
+
Strong revenue growth of 62.0% year-over-year.
-
Operating at a loss with -2.6% margin.
+
Wall Street consensus is "Buy" from 3 analysts.
+
Average analyst target of $4.58 implies 5.7% upside.
Recent News
Loading news...
Last updated: Jul 28, 2026 21:01 UTC
Back to Screener Export Report